The effectiveness of an Oscillating Positive Expiratory Pressure (OPEP) Therapy on respiratory symptoms in patients with COPD/chronic bronchitis with excess mucus in daily clinical practice

The effectiveness of an Oscillating Positive Expiratory Pressure (OPEP) Therapy on respiratory symptoms in patients with COPD/chronic bronchitis with excess mucus in daily clinical practice - OPEP Therapy in COPD/chronische bronchitis patients with excess mucus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42501

Enrollment

106

Registered

2015-12-15

Start date

2016-02-09

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic bronchitis Chronic Obstructie Pulmonary Disease (COPD)

Interventions

Patients will be allocated either to the intervention group (using a hand-held mechanical oPEP device) or the control group (using the sham version of the hand-held device). Patients in both groups

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: clinical diagnosis of COPD or chronic bronchitis (aged 40 years or older) patients with sputum production/excess mucus informed consent

Exclusion criteria

Exclusion criteria: diagnosis of CF or bronchiectasis OPEP use in the past

Design outcomes

Primary

Measure	Time frame
Respiratory symptoms as measured by the Clinical COPD Questionnaire (CCQ).	—

Secondary

Measure	Time frame
Secondary outcomes are subdomainscores of the CCQ, health-related Quality of Life (SGRQ), cough symptoms (LCQ), global rating of change in health status and ability of coughing up sputum, lung function (FEV1 and FVC (L and % predicted)) and exacerbations. In addition data on adherence and patient satisfaction will be collected.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)